Jorgensen Nathan D. 4
4 · Vor Biopharma Inc. · Filed Feb 8, 2023
Insider Transaction Report
Form 4
Jorgensen Nathan D.
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2023-02-06+91,000→ 91,000 totalExercise: $5.55Exp: 2033-02-05→ Common Stock (91,000 underlying) - Award
Common Stock
2023-02-06+45,500→ 160,769 total
Footnotes (2)
- [F1]Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest over four years in equal quarterly installments beginning February 6, 2023, subject to the Reporting Person's continued service as of each such date.
- [F2]The shares shall vest and become exercisable in a series of 48 successive equal monthly installments beginning on February 6, 2023, in each case subject to the Reporting Person's continued service as of each such date.